Catalog

Melanie Wills (Ph.D.) - Bull’s-Eye: Understanding & Diagnosing Lyme Disease Virtual Event - 08/06/2022 12pm (ET)
Online
Added:

FREE FOR MEMBERS!
Description:
Lyme disease is the most common vector-borne infection in the northern hemisphere, where it poses an escalating threat to the health of Canadians. Despite over four decades of investigation into the disease and the causative pathogen, Borrelia burgdorferi, fundamental knowledge gaps remain that impact diagnostic testing, treatment, and outcome, and render Lyme one of the most polarized and politicized diseases of the 21st century. This session will explore the disease from the perspectives of clinical and laboratory medicine, including the challenges and opportunities in the research and development space.

Date: June 8, 2022
Time: 12pm – 1pm (ET)
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
Certificate awarded

About this item

FREE FOR MEMBERS!

Description:

Lyme disease is the most common vector-borne infection in the northern hemisphere, where it poses an escalating threat to the health of Canadians. Despite over four decades of investigation into the disease and the causative pathogen, Borrelia burgdorferi, fundamental knowledge gaps remain that impact diagnostic testing, treatment, and outcome, and render Lyme one of the most polarized and politicized diseases of the 21st century. This session will explore the disease from the perspectives of clinical and laboratory medicine, including the challenges and opportunities in the research and development space.

 

Date: June 8, 2022

Time: 12pm – 1pm (ET)

Course/Activity Information

At the end of this session you will be able to:

  • Identify Lyme disease risk factors, preventive measures, signs and symptoms
  • Describe strengths and limitations of current diagnostic laboratory tests
  • Appreciate research & development efforts to improve lab-based detection of Lyme disease

 

Speaker: Melanie Wills (Ph.D.); Director, G. Magnotta Lyme Disease Research Lab

Melanie completed her doctoral degree in molecular and cellular biology at the University of Guelph, investigating biochemical “wiring” in cells that cause them to misbehave and give rise to diseases like cancer. In 2017, she was appointed as the inaugural Director of the G. Magnotta Lyme Disease Research Lab at the University of Guelph, which she developed from the ground up with a mandate to improve diagnostic testing and treatment. As a chronic disease sufferer herself, Melanie is passionate about innovation that will provide better outcomes for patients.

 

PEP hours: 1.0

CPS credits: 0

*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.

Close
Shopping Cart
Total:  Close

Loading Shopping Cart Items...